Pharma company registered lobbying expenditures for USA

According to OpenSecrets.Org, the pharmaceutical manufacturing sector has reported $115,571,832 in lobbying for 2011, a number that will grow considerably when all quarterly reports are filed. The top lobbying outlays were reported by PhRMA, the trade association, followed by Pfizer, Amgen, Merck, Lilly, Novartis, Bayer and GSK. The top generic company was Teva, which ranked 12th overall. As reported by OpenSecrets, some firms are listed more than once, for lobbying outlays by different subsidiaries. Accounting for reporting by different subsidiaries, PhRMA and the top 4 individual firms reported 40 percent of the total. PhRMA and the top nine firms represented 60 percent of the total. For some reason, OpenSecrets has no data for the trade association BIO in 2011.

The biggest year for pharmaceutical industry lobbying was 2009, the year that the Affordable Health Care bill was passed, when industry lobbying outlays were reported at $186,193,467. OpenSecrets.org reports the number of lobbyists as 825 in 2011.

The reported outlays and employed lobbyists is a small part of the actually effort to influence the government, and does not include many persons who supervise and direct lobbyists, public relations and grass roots organizing campaigns, or lobbying of the FDA, USTR or other executive branch agencies.

$13,970,000 – Pharmaceutical Rsrch & Mfrs of America
$10,700,000 – Pfizer Inc
$7,310,000 – Amgen Inc
$7,125,000 – Merck & Co
$6,735,000 – Eli Lilly & Co
$5,199,948 – Novartis AG
$4,440,000 – Bayer AG
$4,415,000 – GlaxoSmithKline
$3,890,000 – Sanofi-Aventis
$3,440,000 – AstraZeneca PLC
$2,860,000 – Abbott Laboratories
$2,770,000 – Teva Pharmaceutical Industries
$2,300,000 – Novo Nordisk Pharmaceuticals
$2,260,000 – Bristol-Myers Squibb
$1,965,000 – Eisai Co Ltd
$1,850,000 – Kv Pharmaceuticals
$1,845,936 – CH Boehringer Sohn
$1,700,000 – Watson Pharmaceuticals
$1,660,000 – Endo Pharmaceuticals
$1,503,908 – Generic Pharmaceutical Industry Assn
$1,494,821 – Pharmaceutical Care Management Assn
$1,292,123 – Mylan Inc
$1,270,000 – Vertex Pharmaceuticals
$1,160,000 – Takeda Pharmaceutical Co
$1,118,000 – Astellas Pharma USA
$1,100,000 – AstraZeneca PLC
$1,080,000 – Millennium/Takeda Oncology Co
$1,020,000 – Sunovion Pharmaceuticals
$1,010,000 – Cephalon Inc
$880,000 – Cubist Pharmaceuticals
$840,000 – Allergan Inc
$720,000 – Amylin Pharmaceuticals
$715,000 – Celgene Corp
$695,000 – Mylan Inc
$680,000 – Prasco Labs
$655,000 – Consumer Healthcare Products Assn
$618,000 – Lundbeck Inc
$580,000 – Apotex Inc
$520,000 – Ranbaxy Inc
$510,000 – Medicines Co
$500,000 – Hospira Inc
$498,000 – Sanofi-Aventis
$490,000 – Daiichi Sankyo Inc
$430,000 – Bavarian Nordic
$370,000 – Henry Schein Inc
$350,000 – Purdue Pharma
$321,757 – Roche Holdings
$320,000 – Pharma Industry Labor Management Assn
$315,000 – Alexion Pharmaceuticals
$295,000 – Martek Biosciences
$270,000 – Bracco Diagnostics
$270,000 – Council on Radionuclides & Radiopharm
$260,000 – Shire Plc
$240,000 – Vivus Inc
$210,000 – Biocryst Pharmaceuticals
$210,000 – Sepracor Inc
$208,000 – Orexigen Therapeutics Inc
$198,000 – Perrigo Co
$190,000 – XOMA
$170,000 – Forest Laboratories
$160,000 – Leo Pharma
$151,339 – Alkermes Inc
$150,000 – Acorda Therapeutics
$150,000 – America’s Specialty Medicine Companies
$150,000 – Millennium Pharmaceuticals
$150,000 – Momenta Pharmaceuticals
$150,000 – Morton Grove Pharmaceuticals Inc
$140,000 – APP Pharmaceuticals
$120,000 – Canada International Pharmacy Assn
$120,000 – SIGA Technologies
$110,000 – Roche Holdings
$104,000 – Orexigen Therapeutics
$100,000 – iPierian Inc
$90,000 – Breckenridge Pharmaceutical
$90,000 – C-Path Institute
$90,000 – Chimerix
$90,000 – Pharmaceutical Rsrch & Mfrs of America
$80,000 – Alnylam Pharmaceuticals
$80,000 – Nanotherapeutics Inc
$80,000 – Panflu
$70,000 – ARCA Biopharma
$70,000 – Assn of Clinical Research Organizations
$70,000 – Osmotica Pharmaceuticals
$68,000 – Pozen Inc
$65,000 – Myriad Genetics
$60,000 – Cetero Research
$60,000 – Concert Pharmaceuticals
$60,000 – Meda Pharmaceuticals
$60,000 – Millennium Laboratories
$60,000 – Novartis AG
$60,000 – Novavax Inc
$60,000 – Salix Pharmaceuticals
$50,000 – Amyris Biotech
$45,000 – Insmed
$45,000 – Medicis Pharmaceutical Corp
$40,000 – National Center for Genome Resources
$40,000 – Pfizer Inc
$40,000 – Solvay SA
$40,000 – Spectrum Pharmaceuticals
$30,000 – Questcor Pharmaceuticals
$20,000 – Advanced Life Sciences
$20,000 – Agios Pharmaceuticals
$20,000 – Healiance Pharmaceuticals
$20,000 – Onconova Therapeutics
$10,000 – Jazz Pharmaceuticals
$10,000 – Trius Therapeutics
$10,000 – Z-Gen

Categories